blinatumomab,lenalidomide
astellas,amgen
['leusm', 'lenalidomide', 'multiple myeloma', 'blinatumomab', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', ' lena']
congress| #ash22 , shares safety and preliminary efficacy data from the ongoing phase 1 study of adct-602, a cd22 targeting adc bound to pbd toxin, in adult ( 18 years) pts with r/r b-all; well-tolerated overall (one dlt at dose 50 g/kg) #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm